Novel approaches to overcome ALK inhibitor resistance – Complete Phd and Masters Thesis
[ad_1] Introduction Resistance to ALK inhibitors is a major challenge in the treatment of ALK-positive non-small cell lung cancer (NSCLC). Despite the initial success of ALK inhibitors in improving patient outcomes, the development of resistance…
Read More